SOUTHPORT, NC — The American Association of Credentialed Veterinary Technicians (AACVT) today announced its official launch, marking a significant milestone in advancing representation, advocacy, and professional development for credentialed veterinary technicians (CrVTs) across the United States.
Gallant reported positive pilot data for its feline osteoarthritis stem cell therapy, with over 76% of treated cats showing improved quality of life and FDA eligibility granted for an accelerated approval pathway.
USDA APHIS has released an updated response playbook outlining coordinated strategies to prevent, detect, and control New World screwworm in the United States.
After more than a decade building VETgirl into a global veterinary CE community, co-founder Dr. Justine Lee says she will retire this summer and hand leadership to co-founder Dr. Garret Pachtinger.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.
The U.S. pet industry continues to grow steadily, reaching $158 billion in 2025 with projections for further expansion in 2026, as generational shifts and value-driven spending reshape the market.
New research in JAVMA finds dogs with chronic enteropathy are significantly more likely to exhibit anxiety and stress-related behaviors, highlighting a potential gut–brain connection in canine health.
The U.S. FDA has approved Gastrobim (omeprazole) oral paste, the first generic version of omeprazole paste for treating and preventing gastric ulcers in horses and foals.
Creative Diagnostics has introduced a new line of equine disease detection reagents designed to support veterinary diagnostics and research focused on infectious diseases affecting horses.
Parnell has launched nixiFLOR, an FDA-approved injectable solution combining florfenicol and flunixin meglumine for the treatment of bovine respiratory disease and control of fever in beef and non-lactating dairy cattle.
Agtech company Halter has raised $220 million in Series E funding at a $2 billion valuation to accelerate global expansion of its virtual fencing platform used by ranchers and livestock producers.
Apr 30–May 3, 2026 | Indianapolis, IN
Jun 10–Jun 13, 2026 | Seattle
Jun 16–Jun 19, 2026 | Ho Chi Minh City
Jul 9–Jul 12, 2026 | Gulf Shores, AL
Jul 10–Jul 14, 2026 | Anaheim, CA
Qian Hu is launching NATUREAL, a plant-based antimicrobial pet care line derived from upcycled cashew shells, into Germany as part of its European expansion.
Vuzix is entering the veterinary medical space through a new agreement with Movora, bringing its M400 smart glasses to veterinary surgeons for remote support and training.
Gallant reported positive pilot data for its feline osteoarthritis stem cell therapy, with over 76% of treated cats showing improved quality of life and FDA eligibility granted for an accelerated approval pathway.
Elanco has introduced the Advantage Collar for Dogs, an over‑the‑counter parasite control product designed to provide four months of continuous protection against fleas, ticks and mosquitoes.
BioTesserae announced that its PD-1 single domain antibody, BTC-001, was well tolerated in a first-in-dog study, marking a key step toward new immunotherapy options for canine cancer.
Krka has launched Robexera® injectable, the first generic robenacoxib injection in the UK, offering veterinarians a cost-effective option for managing perioperative pain in dogs and cats.
Bimeda has announced the upcoming U.S. launch of Gastrobim™ (omeprazole), the first FDA-approved bioequivalent to GastroGard®, expanding access to equine gastric ulcer treatment.